ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 448

$629K Total Retail Price of All Prescriptions

Rank: 65 out of 448

635 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 635 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 3,974 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 45%.

Prescription Price

$121 was the average price of a prescription from this provider, compared to $111 among peers.

Prescriptions per Patient

8 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 642 452 1 1
METFORMIN HCL 325 234 2 2
INSULIN SYRINGE 279 237 3 9
LANTUS 250 200 4 8
HUMALOG 203 160 5 11
JANUVIA 169 134 6 6
LISINOPRIL 138 107 7 14
AMLODIPINE BESYLATE 136 109 8 12
PEN NEEDLE 128 99 9 5
NOVOLOG 120 110 10 34
GABAPENTIN 117 81 11 30
SIMVASTATIN 114 99 12 4
ATORVASTATIN CALCIUM 108 96 13 13
METHIMAZOLE 94 84 14 24
SENSIPAR 93 84 15 141
ALENDRONATE SODIUM 91 83 16 17
LANTUS SOLOSTAR 90 65 17 10
BYETTA 82 45 18 47
NOVOLOG MIX 70-30 68 58 19 82
GLIMEPIRIDE 67 52 20 7
METFORMIN HCL ER 66 64 21 19
HUMALOG MIX 75-25 63 54 22 45
VICTOZA 3-PAK 61 51 23 64
HYDROCORTISONE 60 22 24 91
DIOVAN 60 41 24 23
NOVOLOG FLEXPEN 57 29 26 28
GLIPIZIDE 57 53 26 15
JANUMET 55 22 28 32
HYDROCHLOROTHIAZIDE 55 55 28 27
FENOFIBRATE 53 37 30 59
LOSARTAN POTASSIUM 53 46 30 16
CARVEDILOL 52 49 32 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.